Rare Copy Number Variants Identified Suggest the Regulating Pathways in Hypertension-Related Left Ventricular Hypertrophy
Left ventricular hypertrophy (LVH) is an independent risk factor for cardiovascular morbidity and mortality, and a powerful predictor of adverse cardiovascular outcomes in the hypertensive patients. It has complex multifactorial and polygenic basis for its pathogenesis. We hypothesized that rare cop...
Main Authors: | Basir, F (Author), Boon-Peng, H (Author), Danuri, N (Author), Jusoh, JAM (Author), Majid, F (Author), Marshall, CR (Author), Scherer, SW (Author), Thiruvahindrapuram, B (Author), Yusoff, K (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Rare copy number variants identified suggest the regulating pathways in hypertension-related left ventricular hypertrophy
by: Basir, F., et al.
Published: (2016) -
Cardiorenal Systems Modeling: Left Ventricular Hypertrophy and Differential Effects of Antihypertensive Therapies on Hypertrophy Regression
by: K. Melissa Hallow, et al.
Published: (2021-06-01) -
Rare Copy Number Variants Identified Suggest the Regulating Pathways in Hypertension-Related Left Ventricular Hypertrophy.
by: Hoh Boon-Peng, et al.
Published: (2016-01-01) -
The Glp-1 Analog Liraglutide Protects Against Angiotensin II and Pressure Overload-Induced Cardiac Hypertrophy via PI3K/Akt1 and AMPKa Signaling
by: Ran Li, et al.
Published: (2019-06-01) -
Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01)